BDBM23917 3-amidinophenylalanine deriv., 59::3-amino-N-(3-{[(2S)-1-[4-(2-aminoethyl)piperidin-1-yl]-3-(3-carbamimidoylphenyl)-1-oxopropan-2-yl]sulfamoyl}phenyl)propanamide::CHEMBL379194

SMILES NCCC1CCN(CC1)C(=O)[C@H](Cc1cccc(c1)C(N)=N)NS(=O)(=O)c1cccc(NC(=O)CCN)c1

InChI Key InChIKey=CEVNTYRWLYLNLF-QHCPKHFHSA-N

Data  10 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 23917   

TargetSuppressor of tumorigenicity 14 protein(Homo sapiens (Human))
Curacyte Discovery

Curated by ChEMBL
LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  3.80nMAssay Description:Inhibition of matriptase (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSuppressor of tumorigenicity 14 protein(Homo sapiens (Human))
Curacyte Discovery

Curated by ChEMBL
LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  6.60nMAssay Description:The measurements were carried out on a microplate reader. Two concentrations of the substrate and five concentrations of the inhibitor were used. Af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Curacyte Discovery

Curated by ChEMBL
LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  2.40E+3nMAssay Description:Inhibition of plasmin (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Curacyte Discovery

Curated by ChEMBL
LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  2.40E+3nMAssay Description:The measurements were carried out on a microplate reader. Two concentrations of the substrate and five concentrations of the inhibitor were used. Af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Curacyte Chemistry

LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  3.60E+3nMAssay Description:The measurements were carried out on a microplate reader. Two concentrations of the substrate and five concentrations of the inhibitor were used. Af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Curacyte Chemistry

LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  3.60E+3nMAssay Description:Inhibition of uPA (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Curacyte Discovery

Curated by ChEMBL
LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  2.10E+4nMAssay Description:Inhibition of factor 10a (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Bos taurus)
Curacyte Chemistry

LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  2.10E+4nMAssay Description:The measurements were carried out on a microplate reader. Two concentrations of the substrate and five concentrations of the inhibitor were used. Af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Curacyte Discovery

Curated by ChEMBL
LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  2.70E+4nMAssay Description:Inhibition of thrombin (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Bos taurus (Bovine))
Curacyte Chemistry

LigandPNGBDBM23917(3-amidinophenylalanine deriv., 59 | 3-amino-N-(3-{...)
Affinity DataKi:  2.70E+4nMAssay Description:The measurements were carried out on a microplate reader. Two concentrations of the substrate and five concentrations of the inhibitor were used. Af...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed